Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase NA 1

Status

Completed 3Not yet recruiting 2Terminated 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Carcinoma, Non-Small-Cell Lung 37Colorectal Neoplasms 28Leukemia, Myeloid, Acute 27Neoplasms 26Recurrence 22Neoplasm Metastasis 22Multiple Myeloma 20Advanced Solid Tumors 20Lymphoma, B-Cell 19Breast Neoplasms 17Pancreatic Neoplasms 14Lung Neoplasms 13Glioblastoma 13Carcinoma, Hepatocellular 13Brain Neoplasms 13Lymphoma 12Glioma 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Melanoma 11Hematologic Neoplasms 11Triple Negative Breast Neoplasms 10Squamous Cell Carcinoma of Head and Neck 10Ovarian Neoplasms 10Leukemia 10Advanced Solid Tumor 10Prostatic Neoplasms 9Head and Neck Neoplasms 9Lymphoma, Non-Hodgkin 8Esophageal Neoplasms 8Sarcoma 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Not yet recruiting × Hepatic Insufficiency × Clear all
NCT07559474 2026-04-30

A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment

Incyte Corporation

Phase 1 Not yet recruiting
16 enrolled
Lymphoid

Liver Diseases, Lymphoma, Follicular, Hepatic Insufficiency

NCT07550634 2026-04-24

Pharmacokinetics and Safety of MDR-001 in Mild and Moderate Hepatic Impairment

MindRank AI Ltd

Phase 1 Not yet recruiting
32 enrolled
Lymphoid

Lymphoma, Follicular, Hepatic Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡